Gregor Krings

4.8k total citations · 1 hit paper
62 papers, 2.8k citations indexed

About

Gregor Krings is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Gregor Krings has authored 62 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 19 papers in Pathology and Forensic Medicine and 17 papers in Surgery. Recurrent topics in Gregor Krings's work include Cancer and Skin Lesions (15 papers), Breast Lesions and Carcinomas (14 papers) and Salivary Gland Tumors Diagnosis and Treatment (11 papers). Gregor Krings is often cited by papers focused on Cancer and Skin Lesions (15 papers), Breast Lesions and Carcinomas (14 papers) and Salivary Gland Tumors Diagnosis and Treatment (11 papers). Gregor Krings collaborates with scholars based in United States, Netherlands and Germany. Gregor Krings's co-authors include Yunn‐Yi Chen, Deepak Bastia, Andrei Goga, Roman Camarda, Gregory R. Bean, Dvir Aran, Harikrishna Paik, Marina Sirota, Atul J. Butte and Boris Oskotsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Gregor Krings

60 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive analysis of normal adjacent to tumor transcriptomes

2017 375 citations Gregor Krings et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Gregor Krings	1.2k	825	813	464	438	62	2.8k
Takashi Fukutomi	883 0.7×	1.2k 1.5×	1.2k 1.4×	403 0.9×	439 1.0×	163	3.1k
Carlo Lucchesi	1.2k 1.0×	1.0k 1.2×	744 0.9×	162 0.3×	923 2.1×	44	3.1k
Alexander C. Mackinnon	1.1k 0.9×	638 0.8×	516 0.6×	272 0.6×	839 1.9×	93	2.7k
Guido Nicolò	987 0.8×	951 1.2×	644 0.8×	512 1.1×	802 1.8×	94	2.9k
Margaret C. Cummings	1.5k 1.2×	1.4k 1.7×	1.0k 1.2×	327 0.7×	383 0.9×	74	3.2k
Xiaomao Guo	502 0.4×	769 0.9×	633 0.8×	447 1.0×	731 1.7×	115	2.2k
K Smith	1.6k 1.3×	1.3k 1.5×	889 1.1×	295 0.6×	412 0.9×	20	3.1k
Bo Baldetorp	1.4k 1.1×	1.5k 1.8×	1.3k 1.7×	206 0.4×	757 1.7×	132	3.6k
Katja Gwin	1.3k 1.0×	659 0.8×	1.3k 1.5×	256 0.6×	285 0.7×	48	2.6k
Fulvio Lonardo	1.3k 1.1×	1.4k 1.7×	457 0.6×	341 0.7×	1.4k 3.2×	79	3.4k

Countries citing papers authored by Gregor Krings

Since Specialization

Citations

This map shows the geographic impact of Gregor Krings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Krings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Krings more than expected).

Fields of papers citing papers by Gregor Krings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Krings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Krings. The network helps show where Gregor Krings may publish in the future.

Co-authorship network of co-authors of Gregor Krings

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Krings. A scholar is included among the top collaborators of Gregor Krings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Krings. Gregor Krings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Aihui, Ishani Das, Ryan Bremer, et al.. (2025). RNA In Situ Hybridization Detection of CRTC1/3::MAML2 Fusions and LINC00473 in Mucoepidermoid Carcinomas and Hidradenomas of Breast, Salivary Glands, and Skin. Modern Pathology. 38(7). 100756–100756. 1 indexed citations

Rathmell, W. Kimryn, Geoffrey I. Shapiro, Naoko Takebe, et al.. (2024). A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2 - Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Research Communications. 4(7). 1793–1801. 6 indexed citations

Krings, Gregor, Eliah R. Shamir, Marick Laé, et al.. (2024). Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. 86(5). 779–792. 1 indexed citations

Schwartz, Christopher J. & Gregor Krings. (2024). Salivary gland-like tumors of the breast: Histopathologic and genetic features with clinical implications. Seminars in Diagnostic Pathology. 41(6). 272–284.

Patel, A., Gregor Krings, Yunn‐Yi Chen, et al.. (2024). Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma. Advances in Radiation Oncology. 9(5). 101448–101448. 2 indexed citations

Schwartz, Christopher J., Gregory R. Bean, Deepika Sirohi, et al.. (2023). Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior. Modern Pathology. 36(5). 100125–100125. 14 indexed citations

Shamir, Eliah R., Gregory R. Bean, Christopher J. Schwartz, et al.. (2023). Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression. Modern Pathology. 36(12). 100324–100324. 6 indexed citations

Cloutier, Jeffrey M., Lin Wang, Christian A. Kunder, et al.. (2023). Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics. Human Pathology. 139. 17–26. 2 indexed citations

Rathmell, W. Kimryn, Geoffrey I. Shapiro, Jordi Rodón, et al.. (2023). A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies.. Journal of Clinical Oncology. 41(16_suppl). 3104–3104. 2 indexed citations

10.

Black, Margaret A., Neil M. Neumann, Gregor Krings, et al.. (2023). Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma. Modern Pathology. 36(10). 100270–100270. 8 indexed citations

11.

Sahoo, Sunati, Gregor Krings, Yunn‐Yi Chen, et al.. (2022). Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Archives of Pathology & Laboratory Medicine. 147(5). 591–603. 5 indexed citations

12.

Ma, Lin, Alba Gonzàlez-Juncà, Yufei Zheng, et al.. (2021). Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy. Clinical Cancer Research. 27(6). 1778–1791. 13 indexed citations

13.

Beça, Francisco, Gregor Krings, Yunn‐Yi Chen, et al.. (2020). Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Modern Pathology. 33(8). 1518–1526. 19 indexed citations

14.

Shamir, Eliah R., Yunn‐Yi Chen, & Gregor Krings. (2020). Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma. Modern Pathology. 33(6). 1078–1091. 13 indexed citations

15.

Bachawal, Sunitha V., Gregory R. Bean, Gregor Krings, & Katheryne E. Wilson. (2020). Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression. npj Breast Cancer. 6(1). 14–14. 14 indexed citations

16.

Shamir, Eliah R., W. Patrick Devine, Melike Pekmezci, et al.. (2018). Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Modern Pathology. 32(2). 290–305. 48 indexed citations

17.

Krings, Gregor, Patrick J. McIntire, & Sandra J. Shin. (2017). Myofibroblastic, fibroblastic and myoid lesions of the breast. Seminars in Diagnostic Pathology. 34(5). 427–437. 15 indexed citations

18.

Krings, Gregor, Gregory R. Bean, & Yunn‐Yi Chen. (2017). Fibroepithelial lesions; The WHO spectrum. Seminars in Diagnostic Pathology. 34(5). 438–452. 57 indexed citations

19.

Jalikis, Florencia G., Gregor Krings, Rodney A. Schmidt, et al.. (2016). ‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study. Modern Pathology. 30(2). 227–235. 68 indexed citations

20.

Krings, Gregor, et al.. (2014). Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Human Pathology. 45(11). 2225–2232. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact